ASAS App vs PlasmaBind Tacrolimus
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ASAS App
This medical app provides essential tools for assessing Ankylosing Spondylitis. It includes calculators for key disease activity scores and offers comprehensive information on diagnosis, classification, and treatment of spondyloarthritis.
- ASDAS calculator
- BASDAI calculator
- Spondyloarthritis classification
- Diagnosis information
- Treatment guidelines
- ASAS Health Index
Read full descriptionHide full description
The ASAS app offers calculators for the Ankylosing Spondylitis Disease Activity Score (ASDAS), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), as well as information on classification, diagnosis, outcome assessment, and treatment of spondyloarthritis. ASAS Health Index
PlasmaBind Tacrolimus
Read full descriptionHide full description
PlasmaBind Tacrolimus is an educational pharmacokinetic simulation tool. This app is intended for educational and research visualization only. It does not provide medical advice, clinical decision support, or dosing recommendations. Always consult qualified healthcare professionals for clinical decisions. Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Privacy Policy: https://plasmabind.ca/privacy
Screenshots
Verdict
The clearest difference is in-app purchases: ASAS App at none against PlasmaBind Tacrolimus's 1. PlasmaBind Tacrolimus's advantage is update cadence (every 9 days vs every 20 months). On price, ads, device support and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. PlasmaBind Tacrolimus sells 1 in-app purchase, starting at $9.99 per year. ASAS App asks for nothing beyond the download.
ASAS App ships an update every 20 months, PlasmaBind Tacrolimus every 9 days. The most recent releases landed on October 17, 2026 and October 28, 2026 respectively.
| Parameter | ASAS App | PlasmaBind Tacrolimus |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | — |
| Number of ratings | 1 — better | — |
| Update frequency | Every 20 months | Every 9 days — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.6 | 15.1 — better |
| Further details — not scored | ||
| Size | 45 MB | 31 MB |
| Age rating | 17+ | 4+ |
| Developer | Stichting Assessment of Spondyloarthritis international Society | PlasmaBind Inc. |
In-app purchases
ASAS App
No in-app purchases
PlasmaBind Tacrolimus
- PlasmaBind Pro$9.991 Year
